Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: $120M in Fees - Using last quarters license fee / revenue ratio

$120M in Fees - Using last quarters license fee / revenue ratio

posted on Mar 18, 2008 09:00PM

If we were to simply look at the last reported quarter and look at the license fees paid versus the annual revenues of those companies that paid them, the overall historical ratio of $1/$1956 drops to $1/$1487 or so.  Simply applying that ratio to the Q3 companies signed, the license fee number would jump to about $122M!  Legitimately, it can be argued that since TPL has said that license fees have increased, the most recent averages would be more accurate than the overall historical average.  With that in mind, I think there can be a good argument made that the total PDS license fees for Q3 are in the $120M range without even accounting for the obvious premium that the J3 is likely to have paid.

Share
New Message
Please login to post a reply